Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials

Hengartner, Michael Pascal; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin

doi:10.1371/journal.pone.0229381

Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19725

Publication type:	Article in scientific journal
Type of review:	Peer review (publication)
Title:	Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials
Authors:	Hengartner, Michael Pascal Jakobsen, Janus C. Sørensen, Anders Plöderl, Martin
et. al:	No
DOI:	10.1371/journal.pone.0229381 10.21256/zhaw-19725
Published in:	PLOS ONE
Volume(Issue):	15
Issue:	2
Page(s):	e0229381
Issue Date:	2020
Publisher / Ed. Institution:	Public Library of Science
ISSN:	1932-6203
Language:	English
Subject (DDC):	616.8: Neurology, diseases of nervous system
Abstract:	It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS).
URI:	https://digitalcollection.zhaw.ch/handle/11475/19725
Fulltext version:	Published version
License (according to publishing contract):	CC BY 4.0: Attribution 4.0 International
Departement:	Applied Psychology
Organisational Unit:	Psychological Institute (PI)
Appears in collections:	Publikationen Angewandte Psychologie

Files in This Item:

File	Description	Size	Format
2020_Hengartner-etal_New-generation-antidepressants.pdf		898.34 kB	Adobe PDF	View/Open

Show full item record

Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. Plos One, 15(2), e0229381. https://doi.org/10.1371/journal.pone.0229381

Hengartner, M.P. et al. (2020) ‘Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials’, PLOS ONE, 15(2), p. e0229381. Available at: https://doi.org/10.1371/journal.pone.0229381.

M. P. Hengartner, J. C. Jakobsen, A. Sørensen, and M. Plöderl, “Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials,” PLOS ONE, vol. 15, no. 2, p. e0229381, 2020, doi: 10.1371/journal.pone.0229381.

HENGARTNER, Michael Pascal, Janus C. JAKOBSEN, Anders SØRENSEN und Martin PLÖDERL, 2020. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. PLOS ONE. 2020. Bd. 15, Nr. 2, S. e0229381. DOI 10.1371/journal.pone.0229381

Hengartner, Michael Pascal, Janus C. Jakobsen, Anders Sørensen, and Martin Plöderl. 2020. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One 15 (2): e0229381. https://doi.org/10.1371/journal.pone.0229381.

Hengartner, Michael Pascal, et al. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One, vol. 15, no. 2, 2020, p. e0229381, https://doi.org/10.1371/journal.pone.0229381.